港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

宝济药业-B

65.600

-0.350-0.53%

成交量：- -

成交额：- -

市值：213.84亿

市盈率：- -

高：65.600

开：65.600

低：65.600

收：65.950

52周最高：70.000

52周最低：56.000

股本：3.26亿

香港流通股本：1.54亿

量比：- -

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：21.76

市盈率(LYR):- -

市销率: 414.83

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

宝济药业-B12月15日主力净流出15.6万元散户资金买入

山东新动能基金公司又一投资企业在港交所上市

宝济药业挂牌港交所，山东国资多点加码生物医药

交银国际作为联席全球协调人助力宝济药业完成港股IPO项目

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02659"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"宝济药业-B","latestPrice":65.6,"timestamp":1765847324161,"preClose":65.95,"halted":0,"volume":0,"delay":0,"floatShares":154000000,"shares":325981465,"eps":0,"marketStatus":"开市前","change":-0.35,"latestTime":"12-16 09:10:11","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":65.6,"askSize":2000,"bidPrice":65.6,"bidSize":600,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":1,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":65.95,"openAndCloseTimeList":[[1765848600000,1765857600000],[1765861200000,1765872000000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":154000000,"roa":"--","roe":"--","lyrEps":0,"shares":325981465,"dividePrice":0,"high":65.6,"amplitude":0,"preClose":65.95,"low":65.6,"week52Low":56,"pbRate":"21.76","psRate":"414.83","week52High":70,"institutionHeld":0,"latestPrice":65.6,"committee":-0.538462,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":65.6,"prevYearClose":26.38,"fiveDayClose":26.38,"twentyDayClose":26.38,"sixtyDayClose":26.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2025-12-12","current":-53.146224,"percent":0.333333,"low":-53.651638,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"high":-20.527356,"avg":-44.088096,"sd":13.720549,"marketCap":22280833132},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132}],"updateTime":1765811224265},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591616778","title":"宝济药业-B12月15日主力净流出15.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591616778?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 16:15","pubTimestamp":1765786536,"startTime":"0","endTime":"0","summary":"12月15日, 宝济药业-B股价跌3.51%，报收65.95元，成交金额5059.6万元，换手率0.50%，振幅6.14%，量比0.00。宝济药业-B今日主力资金净流出15.6万元，上一交易日主力净流入13.1万元。该股近5个交易日上涨148.67%，主力资金累计净流入563.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入563.7万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161815a44d2d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161815a44d2d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":0},{"id":"2591682812","title":"山东新动能基金公司又一投资企业在港交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2591682812","media":"国企研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591682812?lang=zh_cn&edition=fundamental","pubTime":"2025-12-13 06:30","pubTimestamp":1765578645,"startTime":"0","endTime":"0","summary":"12月10日，新动能基金公司投资企业上海宝济药业在香港联合交易所主板挂牌上市，发行价26.38港元，首日股价暴涨139%，市值突破205亿港元，成为2025年港股第23家上市的医药企业，也成为公司收获的第116家投资上市企业。新动能基金公司于2021年通过山东新旧动能转换基金对宝济药业进行投资，助力企业打通研发、临床与产业化路径，持续陪伴企业穿越创新周期，最终走向资本市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213063608a69cc39c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251213063608a69cc39c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":0},{"id":"2590504723","title":"宝济药业挂牌港交所，山东国资多点加码生物医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2590504723","media":"大众日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590504723?lang=zh_cn&edition=fundamental","pubTime":"2025-12-12 22:01","pubTimestamp":1765548074,"startTime":"0","endTime":"0","summary":"宝济药业在招股书中解释称，“绝大部分的净亏损主要产生自研发开支及行政开支”。尽管尚未盈利、研发投入高企，宝济药业仍受到资本市场关注，并获得山东资本的多轮支持，亦折射出山东国资在创新生物医药赛道的持续布局。从宝济药业招股书披露的IPO前投资者名单来看，山东本地国有资本的身影清晰可见。山东财欣也称，其于2021年及2024年通过基金对宝济药业进行了两轮投资。此次宝济药业上市，成为财欣投资公司累计收获的第五个IPO项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212220329a44516ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212220329a44516ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":1},{"id":"2590519099","title":"交银国际作为联席全球协调人助力宝济药业完成港股IPO项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2590519099","media":"交银国际","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590519099?lang=zh_cn&edition=fundamental","pubTime":"2025-12-11 21:41","pubTimestamp":1765460485,"startTime":"0","endTime":"0","summary":"宝济药业本次全球发售定价每股26.38港元，发行37,911,700股H股，融资规模约为10.00亿港元。交银国际担任联席全球协调人、联席账簿管理人兼联席牵头经办人，全程高效助力宝济药业顺利登陆港股资本市场。宝济药业已布局多个治疗领域的自主管线，拥有12款自主开发的在研和上市产品。通过将稳健的生产体系与前瞻性的研发能力深度融合，宝济药业已形成“创新研发—生物制造—临床转化”一体化的全产业链布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211214729a699b2f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211214729a699b2f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659","BK1147","03329"],"gpt_icon":1}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02659\",params:#limit:6,delay:false,,,undefined,":[]}}